✦ LIBER ✦

Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia

✍ Scribed by Si-Xuan Qian; Jian-Yong Li; Tian Tian; Yun-Feng Shen; Yuan-Qiang Jiang; Hua Lu; Han-Xin Wu; Su-Jiang Zhang; Wei Xu

Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 219 KB
Volume: 31
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2007.02.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with low-dose c

Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient

Treatment of therapy-related acute myelo

Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor

✍ Hiro Tatetsu; Fumihiko Matsuno; Noritaka Takatsu; Hirosada Miyake; Koyu Hoshino; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Salvage therapy with endostatin, low-dos

Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia

✍ Baijun Fang; Yuzhang Liu; Jian Zhou; Yanan Li; Yongping Song 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

Granulocyte-Macrophage colony stimulatin

Granulocyte-Macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia

✍ Paul S. Frenette; Jane F. Desforges; David P. Schenkein; Arthur Rabson; Christop 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

Continuous drip infusion of low dose cyt

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

✍ Nobuhiro Kanemura; Hisashi Tsurumi; Senji Kasahara; Takeshi Hara; Toshiki Yamada 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## Backgrounds and objectives The optimal strategy for the management of elderly patients with acute myeloid leukaemia (AML) is still controversial. We previously reported the effectiveness of low dose cytarabine (Ara‐C) and etoposide (VP‐16) (AV therapy) for those elderly AML patients